Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06920992 · ClinicalTrials.gov registry record · NA

Cognitive Control Functions of the Human Thalamus

A NA study, sponsored by Kai Hwang.

Completed
Registry status
NA
Development phase
184
Enrollment target

NCT06920992: Completed NA study, sponsored by Kai Hwang.

NCT06920992 is a NA study that has completed, run by Kai Hwang. The registered enrollment target is 184 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06920992, a NA study, has completed, sponsored by Kai Hwang.

COMPLETED
Registry status
NA
Development phase
184 participants
Enrollment target

Study Summary

The goal of this research project is to investigate how brain lesions affect our ability to generate goal-directed behaviors - a cognitive function commonly referred to as cognitive control. To support goal-directed behaviors, the human brain must adaptively direct thoughts and actions depending on the current goals and contexts. Our principal hypothesis is that this cognitive capacity depends on a brain network architecture that can flexibly transmit, select, and inhibit information along neural pathways. Therefore, lesions and damages to critical brain network components will negatively affect behavior. To faithfully assess the structure and function of human brain networks and its disruption from brain lesions, investigators will recruit healthy adult human subjects and patients with brain lesions to participate in a multi-session study that includes cognitive behavioral tests, structural magnetic resonance imaging (MRI) using a 3 Tesla (3T) scanner, and electroencephalography (EEG) studies. During all testing sessions, subjects will perform cognitive tasks that assess their ability to select, maintain, and inhibit sensory information and generate motor responses. Their eye movements may be passively recorded during testings. 3T MRI allows for fast and high-resolution imaging of brain structures, enabling us to identify lesion loci. Investigators will use EEG to measure the electrophysiology of brain activities. All behavioral, EEG, and MRI data collected will be sent to the National Institute of Mental Health Data Archive (NDA) at the National Institute of Mental Health (NIMH).

Primary Outcome

Accuracy measure of the behavioral task will determine whether the hypothesized cognitive function of cognitive flexibility is impaired. Impairment will lead to below chance response.

Interventions

  • BEHAVIORAL Working memory and set-switching tasks

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2020-03-10
Est. Completion 2025-12-31
Phase NA
Kai Hwang

2 total trials

What the finished NCT06920992 record still lists

NCT06920992 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 1 intervention - of which Working memory and set-switching tasks is the first listed.

NCT06920992 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06920992 about?

NCT06920992 is a clinical study titled "Cognitive Control Functions of the Human Thalamus". The goal of this research project is to investigate how brain lesions affect our ability to generate goal-directed behaviors - a cognitive function commonly referred to as cognitive control. To support goal-directed behaviors, the human brain must adaptively direct thoughts and actions depending on ...

What is the current status of trial NCT06920992?

This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2020-03-10. Estimated completion is 2025-12-31.

What interventions are being tested in trial NCT06920992?

The interventions under investigation include: Working memory and set-switching tasks (BEHAVIORAL).

Who is sponsoring clinical trial NCT06920992?

This trial is sponsored by Kai Hwang, which has 2 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06920992's enrollment target sits among peer trials

184 581st of 2000 higher than 1,417 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03903510 · 184 participants · NA

    Virtual Reality During Pediatric Cast Removal

  • NCT04020510 · 184 participants · Phase 4

    Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder

  • NCT04135846 · 184 participants · Phase 2

    Alpha-1 Blockade for Alcohol Use Disorder (AUD)

  • NCT04396873 · 184 participants · Phase 1

    PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06920992, the US trial registry maintained by the National Library of Medicine. NCT06920992 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.